HCPCS Code J0652

Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg
Code effective Jul 01, 2024

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J0652 is a valid 2026 HCPCS code meaning Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg or (Inj, levothyroxine, hikma) for short. HCPCS J0652 has been effective since 07/01/2024 and applies to Medical care.


HCPCS Code Details - J0652

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J0652
Description

Long description:
Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg

Short description:
Inj, levothyroxine, hikma

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
ASC payment group code Effective Apr 01, 2024 - This procedure is approved to be performed in an ambulatory surgical center.
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jul 01, 2024
Date added Added Apr 01, 2024

See also

  • HCPCS J0650 · Injection, levothyroxine sodium, not otherwise specified, 10 mcg

  • HCPCS J0651 · Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg

  • HCPCS J0654 · Injection, liothyronine, 1 mcg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”


HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.